We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A new report by the UK's national academy of science, the Royal Society, claims that pharmacogenetics -- gene-based treatments tailored specifically for individual patients --"show promise" but are still 1520 years away from entering widespread use.
The William J Clinton Foundation, a charitable organisation founded by the former US president, has pledged to provide as many ARVs drugs for Chinese children infected with HIV/AIDS as required.
Gene Logic Inc. (NASDAQ: GLGC) announced today that it has entered into an agreement with Pfizer Inc. to seek new therapeutic indications for a significant number of unapproved drug candidates that are not currently in active development.
Med Services Europe GmbH, a "Virtual European Headquarters" for Pharmaceutical and Medical Manufacturers, announced that it has obtained rights to out-license a portfolio of prescription pharmaceuticals and is beginning its search for partners in Russia and the rest of Eastern and Central Europe.
The Serious Fraud Office is investigating allegations that a large sum of money has been misappropriated from Merlin Biosciences, the biotechnology investment fund run by the high-profile entrepreneur Sir Christopher Evans.
Palatin Technologies, Inc. (Amex: PTN -- News) announced today the receipt of $10 million from King Pharmaceuticals, Inc. (NYSE: KG -- News) pursuant to their strategic alliance to jointly develop PT-141 for the treatment of male and female sexual dysfunction.
Drug maker Ranbaxy Laboratories Ltd (RLL) on Tuesday said it has entered into a licensing agreement with Lupin Laboratories Ltd to market the latter's tuberculosis brand in the West and North African markets.
Croatian pharmaceutical concern Pliva (PLV.xq.L: Quote, Profile, Research) has signed a new three-year agreement with Pfizer (PFE.N: Quote, Profile, Research) to supply its best-selling drug azithromycin in bulk, the company said on Monday.